Neurohumoral control mechanisms in congestive heart failure

Jay N Cohn, T. Barry Levine, Gary S Francis, Steven Goldsmith

Research output: Contribution to journalArticlepeer-review

124 Scopus citations

Abstract

Neurohumoral vasoconstrictor systems may play an important role in the hemodynamic derangement and natural history of congestive heart failure (CHF) by raising impedance to left ventricular ejection and shifting blood centrally to augment cardiac filling. Activation of the sympathetic nervous system, the renin-angiotensin system, and the antidiuretic hormone-vasopressin system can be demonstrated in clinical CHF by increased plasma levels of norepinephrine, renin activity, and arginine vasopressin. Because the magnitude of increase in each of these hormones varies widely from patient to patient, profiling of the neurohumoral response might provide new insight into the mechanisms of regulation of the circulation in CHF and into specific management with drugs to inhibit or reverse the vasoconstrictor process. Preliminary encouraging experience with converting-enzyme inhibitors to block formation of angiotensin II and alpha-receptor blockers to inhibit norepinephrine-induced vasoconstriction raise the possibility that selective therapy may eventually have a place in long-term management of CHF. Controlled trials in a larger patient population are now required.

Original languageEnglish (US)
Pages (from-to)509-514
Number of pages6
JournalAmerican Heart Journal
Volume102
Issue number3 PART 2
DOIs
StatePublished - Sep 1981

Bibliographical note

Funding Information:
From the Cardiovascular Division, Department Minnesota Medical School, and the Veterans Supported in part by grants from the National Institute (HL22977) and from the Veterans Service.

Fingerprint

Dive into the research topics of 'Neurohumoral control mechanisms in congestive heart failure'. Together they form a unique fingerprint.

Cite this